A new study reveals the rising burden of liver cancer, highlighting the significant impact of metabolic risk factors like ...

Data from Hengrui’s Phase II trial for its GLP-1/GIP product demonstrated a statistically significant mean weight loss of ...

A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...

The Series A funding round by the start-up, co-founded by executives of Aiolos Bio, the biotech that was sold to GSK last ...

Liver cancer is a leading cause of cancer-related deaths worldwide, with distinct geographic patterns in its incidence.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

-- Most important technology trends: AI, robotics, space, autonomous vehicles, crypto, the app economy and social media. -- Most important macroeconomic trends: Higher interest rates, higher inflation ...

Financing was co-led by Forbion and General Atlantic, with participants such as RA Capital Management, OrbiMed, and Lilly ...

Naturally, more work is needed. Although GLS -1 agonists have been used in diabetes for 20 years, some of the newer findings ...

Brazilian reality television star Gabriel Freitas died on December 30 following a heart attack. After his astonishing weight ...